Can 18 F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?
Yash JainArchi AgrawalAmit JoshiSantosh MenonGagan PrakashVedang MurthyNilendu PurandareSneha ShahAmeya PuranikSayak ChoudhuryVarun ShuklaIndraja DevKumar PrabhashVanita NoronhaVenkatesh RangarajanPublished in: Nuclear medicine communications (2024)
FDG PET/CT with the use of metabolic PET parameters can differentiate between different histopathological subtypes of RCC. Incorporation of metabolic parameters into clinical practice can potentially noninvasively identify patients with low-grade vs. high-grade RCC.